Investors of Geron Corporation Face Class Action Lawsuit Over Securities Fraud Claims

Levi & Korsinsky Files Class Action Lawsuit for Geron Corporation Investors

On April 22, 2025, Levi & Korsinsky, LLP, a law firm known for its dedication to protecting investors' rights, announced the initiation of a class action lawsuit on behalf of investors in Geron Corporation (NASDAQ: GERN). This legal action arises from claims concerning securities fraud that potentially affected investors who held shares in Geron between February 28, 2024, and February 25, 2025.

Background of the Case

The lawsuit aims to secure damages for investors negatively impacted by misleading statements made by Geron's management regarding the commercial potential of their lead product, Rytelo (imetelstat). According to the complaint, the defendants provided optimistic projections about Rytelo's market performance and the company's overall strategy to meet an unmet medical need among first-line ESA ineligible patients. These claims were accompanied by reassurances about tackling competition and risks associated with the drug's required monitoring regimen.

However, on February 26, 2025, the situation took a downturn. Geron published its financial results for the fourth quarter of fiscal year 2024, revealing that the anticipated growth of Rytelo had stagnated. The company blamed external factors such as competition, seasonality, and insufficient awareness of the drug, alongside the complexities of the monitoring requirements, which led to a significant decline in the stock price. Specifically, Geron's stock fell from $2.37 on February 25, 2025, to $1.61 just a day later—a staggering drop of 32.07%, wiping out substantial investor value.

Next Steps for Investors

Any investor who experienced financial losses during this time period is encouraged to take action before the upcoming deadline of May 12, 2025. Those affected can request the court to appoint them as a lead plaintiff in the class action, though it's important to note that participation in any recovery does not mandate serving in this role.

Levi & Korsinsky emphasizes that class members may be eligible for compensation without incurring any out-of-pocket costs or fees—a critical point for many investors concerned about the financial implications of legal proceedings.

Levi & Korsinsky’s Credentials

With a robust history of success in securities litigation spanning two decades, Levi & Korsinsky has secured hundreds of millions in recoveries for shareholders. The firm has been consistently recognized among the top securities litigation firms in the U.S. by ISS Securities Class Action Services due to the high stakes and complexity of the cases they handle. Levi & Korsinsky is committed to supporting its clients and has a dedicated team of more than 70 professionals focused on achieving justice for investors.

Interested parties can connect with Levi & Korsinsky for more details on the lawsuit or to discuss their eligibility for participation. Investors may reach out to Joseph E. Levi or Ed Korsinsky directly via email or phone.

In conclusion, the class action lawsuit represents a significant opportunity for Geron Corporation investors to recover potential losses stemming from alleged securities fraud. The full impact of this legal challenge will depend on the actions of affected investors in the coming weeks.

Contact Information

For additional queries or to join the class action, investors can contact:
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
Levi & Korsinsky, LLP
Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
Email: info@zlk.com
Phone: (212) 363-7500